Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).

被引：1
|
作者：
Krantz, Benjamin A.
Tsui, Dana
Lowery, Maeve Aine
Capanu, Marinela
Yu, Kenneth H.
Kelsen, David Paul
Gedvilaite, Erika
Zhang, Liguo
Selcuklu, S. Duygu
You, Daoqi
Pernicka, Jennifer S. Golia
Do, Richard K. G.
Iacobuzio-Donahue, Christine A.
O'Reilly, Eileen Mary
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Trinity Coll Dublin, Dublin, Ireland
[3] Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.316
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
316
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neuroplastic Changes in a Mouse Model of Pancreatic Ductal Adenocarcinoma (PDAC)
    Stopczynski, Rachelle E.
    DePinho, Ronald A.
    Ying, Haoqiang
    Schwartz, Erica S.
    Albers, Kathryn M.
    Davis, Brian M.
    Bielefeldt, Klaus
    GASTROENTEROLOGY, 2010, 138 (05) : S62 - S62
  • [32] Hereditary pancreatitis (HP) and the risk of pancreatic ductal adenocarcinoma (PDAC)
    Howes, N
    Lerch, MM
    Charnley, R
    Mössner, J
    Endres, S
    Deviere, J
    Verreman, V
    Lucidi, V
    Ohla, A
    Ihse, I
    Imrie, C
    Steenbergan, W
    Poll, A
    Greenhalf, W
    Ellis, I
    Mountford, R
    Whitcomb, DC
    Neoptolemos, JP
    GUT, 2002, 50 : A43 - A43
  • [33] Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
    Koustoulidou, S.
    Knight, J. C.
    Kersemans, V.
    O'Neill, E.
    Cornelissen, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S230 - S230
  • [34] Exploring therapeutic strategies against pancreatic ductal adenocarcinoma (PDAC).
    Liaki, Vasiliki
    CANCER RESEARCH, 2021, 81 (22) : 58 - 59
  • [35] Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
    Chen, Hao
    Yang, Gang
    Xiao, Jianchun
    Zheng, Lianfang
    You, Lei
    Zhang, Taiping
    CANCER LETTERS, 2020, 490 : 12 - 19
  • [36] Elucidating role of bacteria during pancreatic ductal adenocarcinoma (PDAC).
    Chandra, Vidhi
    Le Roux, Olivereen
    Riquelme, Erick
    Zhang, Yu
    Maitra, Anirban
    White, James. R.
    McAllister, Florencia
    CANCER RESEARCH, 2020, 80 (08) : 27 - 27
  • [37] Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
    Pervin, Jannat
    Asad, Mohammad
    Cao, Shaolong
    Jang, Gun Ho
    Feizi, Nikta
    Haibe-Kains, Benjamin
    Karasinska, Joanna M.
    O'Kane, Grainne M.
    Gallinger, Steven
    Schaeffer, David F.
    Renouf, Daniel J.
    Zogopoulos, George
    Bathe, Oliver F.
    FRONTIERS IN GENETICS, 2023, 14
  • [38] Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC
    Oba, A.
    Bao, Q. R.
    Barnett, C. C.
    AI-Musawi, M. H.
    Croce, C.
    Schulick, R. D.
    Del Chiaro, M.
    SCANDINAVIAN JOURNAL OF SURGERY, 2020, 109 (01) : 18 - 28
  • [39] Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)
    Jacobs, Michelle F.
    Stoffel, Elena M.
    FAMILIAL CANCER, 2024, 23 (03) : 221 - 232
  • [40] Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
    Shao, Huilin
    Zhang, Yue
    Yan, Jie
    Ban, Xinchao
    Fan, Xiaojie
    Chang, Xiaoyan
    Lu, Zhaohui
    Wu, Yan
    Zong, Liju
    Mo, Shengwei
    Yu, Shuangni
    Chen, Jie
    ONCOTARGETS AND THERAPY, 2021, 14 : 2163 - 2175
12345